Keryx Biopharmaceuticals is recalling 2,488 bottles of Auryxia (ferric citrate) 210 mg tablets because damaged moisture-absorbing packets (StripPax) inside the bottles may have leaked silica gel granules. These granules can come into direct contact with the tablets, creating a foreign substance contamination issue. This recall affects 200-count bottles from lot number AH3842 that were distributed nationwide in the United States.
If the silica gel granules from a damaged desiccant packet are accidentally ingested along with the medication, they may pose a choking hazard or cause digestive irritation, though the risk level is currently classified as low.
Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.